Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LARRY LYNN FRASE

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1942242995
CMS profile
617655
Location
LONGVIEW, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$991.15

35 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $594.05 31
Long term medical supply or device loan $299.10 3
Education $98.00 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LARRY LYNN FRASE

NPI 1942242995 · CMS profile ID 617655

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

LONGVIEW, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1942242995?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LARRY LYNN FRASE, NPI 1942242995, CMS profile ID 617655. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1942242995?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). LARRY LYNN FRASE, NPI 1942242995, CMS profile ID 617655. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1942242995?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
LARRY LYNN FRASE, NPI 1942242995, CMS profile ID 617655, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–35 of 35 matching records. This page contains 35 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1942242995?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

35 matching records · $991.15 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 35 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–35 of 35.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Regeneron Healthcare Solutions, Inc. $27.8711/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999176833 CMS
Pharmacyclics LLC, An AbbVie Company $13.5211/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998285649 CMS
Blueprint Medicines Corporation $21.5111/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051266003 CMS
Stemline Therapeutics Inc. $16.9411/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040030779 CMS
AstraZeneca Pharmaceuticals LP $19.9711/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011291745 CMS
Novartis Pharmaceuticals Corporation $12.7611/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991639499 CMS
GlaxoSmithKline, LLC. $20.6210/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001678037 CMS
Sun Pharmaceutical Industries Inc. $18.7010/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053900291 CMS
E.R. Squibb & Sons, L.L.C. $13.5510/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015498505 CMS
SOBI, INC $20.4410/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038140167 CMS
Pharmacyclics LLC, An AbbVie Company $28.5510/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998285647 CMS
Merck Sharp & Dohme LLC $21.5910/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048841219 CMS
Novartis Pharmaceuticals Corporation $23.8509/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991639493 CMS
Mirati Therapeutics, Inc. $20.5909/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057990959 CMS
GENZYME CORPORATION $24.6309/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050424535 CMS
GlaxoSmithKline, LLC. $18.3009/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001677969 CMS
AstraZeneca Pharmaceuticals LP $17.8209/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015963359 CMS
Bayer Healthcare Pharmaceuticals Inc. $31.4908/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000698079 CMS
GlaxoSmithKline, LLC. $19.5708/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001677999 CMS
Merck Sharp & Dohme LLC $17.6708/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048664533 CMS
Alnylam Pharmaceuticals Inc. $17.2408/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006190669 CMS
Astellas Pharma US Inc $17.4308/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034388349 CMS
Novartis Pharmaceuticals Corporation $18.4007/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991639487 CMS
Pharmacyclics LLC, An AbbVie Company $98.0007/13/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998285645 CMS
SOBI, INC $20.5007/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038110983 CMS
Blueprint Medicines Corporation $13.5206/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051265615 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7005/31/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993431757 CMS
AstraZeneca Pharmaceuticals LP $14.3505/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012082743 CMS
CTI BioPharma Corp. $17.3905/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039692695 CMS
Seagen Inc. $13.4905/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995801087 CMS
Jazz Pharmaceuticals Inc. $19.5705/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059097167 CMS
Novartis Pharmaceuticals Corporation $13.5604/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991639477 CMS
AstraZeneca Pharmaceuticals LP $18.6604/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014880975 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7002/15/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993431755 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7001/14/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993431753 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $24.67 2
PY2022 $522.23 14
PY2023 $991.15 35
PY2024 $2,066.88 60
PY2025 $1,674.24 42

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $9,500.00 1
PY2022 Principal investigator $8,075.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $9,500.00 04/24/2023 Non-covered Recipient Entity
US ONCOLOGY RESEARCH INC
A Phase 3, Open-Label, Randomized Study of Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy Compared with Platinum-Based Chemotherapy in Patients with EGFR-Mutated Locally Advanced or Metastatic NonSmall Cell Lung Cancer After Osimertinib Failure No dispute reported 06/30/2026 986155861